| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.48M | - | |
| Dir | 4.52M | $14.61M | - | |
| CEO | 2.26M | $7.31M | - | |
| Dir | 1.24M | $4.01M | - | |
| Other | 1.11M | $3.58M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 39,420 | $6.60 | $259,991.26 | -5.5% | +35.2% | -2.0% | |
| Apr 7, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 39,218 | $6.54 | $256,519.87 | -5.9% | +35.0% | -0.6% | |
| Apr 6, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 38,326 | $6.76 | $259,118.73 | -6.2% | +33.1% | 0.0% | |
| Apr 5, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 36,972 | $7.43 | $274,517.73 | -6.6% | +24.3% | -9.4% | |
| Mar 15, 2022 | Gibson Christopher70 | Chief Executive Officer | Sell | 336,150 | $6.48 | $2,176,801.38 | -32.4% | -7.2% | +19.7% | |
| Mar 7, 2022 | Gibson Christopher70 | Chief Executive Officer | Sell | 300,000 | $7.30 | $2,188,950.00 | -56.2% | +1.1% | +16.4% | |
| Feb 22, 2022 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $10.22 | $1,021,540.00 | -29.9% | -42.9% | -21.9% | |
| Jan 31, 2022 | Gibson Christopher70 | Chief Executive Officer | Sell | 19,858 | $11.73 | $232,964.13 | -45.8% | -44.2% | -29.6% | |
| Jan 14, 2022 | Gibson Christopher70 | Chief Executive Officer | Sell | 341,000 | $13.76 | $4,692,177.31 | -81.2% | -46.0% | -37.0% | |
| Jan 4, 2022 | Borgeson Blake69 | Director | Sell | 9,625 | $18.03 | $173,528.16 | -0.1% | -56.7% | -56.6% |